MIAMI, FL / ACCESSWIRE / November 25, 2020 / The holidays are upon us, and with the traditional "shopping season" in full swing, eCommerce businesses are scrambling to button up last-minute deals and strategies to make this season a great one (despite the economic downturn).

According to the National Retail Federation (NRF), holiday shopping between November and December has traditionally represented 19% or more of the entire year's sales for many businesses. In light of COVID and a consumer shift from in-store to online shopping, this year is projected by some to be a challenging one for many eCommerce businesses caught off guard by the influx of online shoppers.

Research published on CNBC and others suggests that up to 44% of consumers plan on spending less this holiday season. According to Next Level Marketing, this makes partnering with a reputable marketing company that much more important for the 2020 holiday season.

Next Level Marketing Taps Into the Holiday Shopping Craze

The holiday season is, first and foremost, about family and being thankful. But beyond that, it is a time when shoppers splurge at the checkout. Next Level Marketing brings decades of experience to the table, having helped hundreds of clients, from budding startups to multinational corporations navigate the holiday season rush with stride.

For those looking to capitalize on the seasonal shopping bonanza, few channels produce as good of results as eCommerce SEM and eCommerce SEO. When used together, these two digital marketing strategies pack a 1-2 knockout punch, delivering scalable and reliable results with paid ads, while leveraging the power of organic (free) traffic that lasts well beyond the holiday rush.

eCommerce SEO and SEM

eCommerce SEO

eCommerce platforms pose unique challenges when it comes to search engine optimization. Complex code, hundreds or even thousands of SKUs, coupons, code structure, CMS limitations, and more all add to the difficulty of getting it done right.

Due to the complexity, and potential to do more harm than good, Next Level Marketing stresses the importance of partnering with a digital marketing agency that has a deep working knowledge of eCommerce platforms, and that knows how to best leverage its strengths while mitigating any weaknesses in order to get the most out of any strategies employed.

eCommerce SEM

Google search is a critical element in the buying cycle for virtually all goods and services, with more than 83% of all sales cycles having search as a key touchpoint in the buying decision process. Properly optimizing this channel before the peak season can set up a business for long-term success well beyond the holiday shopping months.

Elements of eCommerce SEO Include:

Keyword optimization
Site architecture structuring and restructuring
Product descriptions and headlines optimization
On-page SEO and local SEO optimization
Link-building strategies
Enhancing the user experience
Optimizing for conversion rates
Implementing dynamic tracking to measure site performance
And more…

Elements of eCommerce SEM Include:

Ad design and testing
Audience targeting
Audience segmentation
Retargeting campaigns
Cart abandonment campaigns
Budget optimization
And more…

What Businesses Can Do Right Now to Prepare

Next Level Marketing warns to avoid waiting until the last minute. There is no time like yesterday to begin planning and executing a strategy.

Ideas to Get Started on, and what to avoid:

Holiday deals
Holiday-specific product categories and landers
Repositioning content
Adding structured data
Increase customer service hours
Speak with hosting providers about elastic increases in resources
Shore up any errors or issues that may impact performance
And more…

About Next Level Marketing

Next Level Marketing is one of the nation's leading marketing firms, backed by an impressive resume of results for clients large and small. Having worked with businesses ranging from local mom and pop operations, to multinational Fortune 500 companies, Next Level Marketing is capable and ready to tackle any challenge this holiday season.

Those interested in learning more about NLM or in partnering with an award-winning digital marketing agency this season, are encouraged to reach out via their official website.

CONTACT:

Company Name: Next Level Marketing
Contact Person: Tomas Gallo
Email: tomas@nextlevelsem.com
Phone: (844) 740-5010
Address: 2125 Biscayne Blvd, Miami FL 33137
Website: www.nextlevelsem.com

SOURCE: Next Level Marketing

ReleaseID: 618356

MONTEVIDEO, URUGUAY / ACCESSWIRE / November 25, 2020 / Money On Chain is pleased to announce the launch of TEX, a new decentralized token exchange built on RSK, Bitcoin's smart contract sidechain. TEX automates token swaps using smart contracts, offering users access to DoC, BPro, RIF, and rBTC, among others. The launch further expands the footprint of Bitcoin DeFi based on the RSK technology stack.

The TEX uses a unique trading mechanism, inspired by the method used at The London Gold Fix, which sets the value of gold twice a day. Based on an Order Book (OB), the order execution is not instantaneous and occurs on ticks. Ticks occur every few minutes to allow the order book to form a price to be discovered before the match is made. The frequency of ticks depends on market activity. This is especially important in a new network and enables organic liquidity growth. Users who place orders in the OB can cancel them at any time.

With the public order book, the TEX design avoids front-running, and with pricing via ticks, TEX aims to ensure a fairer price discovery, even at low trading volume.

Max Carjuzaa, co-founder of Money On Chain commented: "The TEX is an important piece of the Money On Chain protocol. The decentralized order book ensures a fair and transparent price discovery process and establishes a secondary market for tokens."

The TEX has two types of orders: Limit Orders and Market Maker Orders.

A limit order lets the trader set the trade conditions to ensure that they buy or sell at the intended price or better. The buyer will not spend more than the maximum they were willing to pay, and the seller will not receive less than the minimum they were expecting to obtain. The price will be the average between the two.

A market maker order is a special type of limit order. Here, the trader specifies a percentage difference with a fair price. The TEX obtains fair pricing from an oracle or the last tick where an oracle is not available.

TEX is designed to be a fairer way to trade in a Bitcoin ecosystem. TEX is already live, so traders can immediately start trading in a decentralized and transparent manner.

Diego Gutierrez Zaldivar, CEO of IOVlabs added: "We are very excited about this announcement that shows momentum for Bitcoin Defi is growing. Decentralized exchanges, together with sovereign digital identities will play a key role in Bitcoin's future and provide the core tools for financial freedom."

For more information about the TEX visit: https://moneyonchain.com/tex-bitcoin-decentralized-exchange/

About Money on Chain

Money On Chain wants to bring Bitcoin to mass adoption. To that end, it offers solutions to meet the needs of different types of users: a fully bitcoin-collateralized stablecoin (DoC), a bitcoin on steroids (BPro) and a dizzying bitcoiner option for lovers of leveraged trading (BTCx). All this, without requiring the delivery of private keys. To make this possible, it developed an unique mathematical-financial model with proven robustness, even in extreme market situations.

For more information, visit https://moneyonchain.com/

About RSK

The RSK network is the most secure smart contract platform in the world, secured by Bitcoin's unparalleled hash power via merge-mining.

RSK adds value and functionality to the bitcoin ecosystem by enabling smart-contracts, near instant payments, and higher-scalability.

The network scales to up to 100 transactions per second without sacrificing decentralization, and reduces storage and bandwidth using probabilistic verification, fraud detection, and more.

For more information visit https://www.rsk.co/rsk-blockchain/

Contact

Dan Edelstein
pr@marketacross.com
+972-545-464-238

SOURCE: IOV Labs

ReleaseID: 618339

LOS ANGELES, CA / ACCESSWIRE / November 25, 2020 / Kevin Lenaghan is excited to announce the launch of a new business venture, Ivy Academy LLC ("the company"). Based in Los Angeles, California, the company provides investment advisory services for sophisticated global investors, as well as admissions counseling services.

Ivy Academy LLC's investment advisory division provide bespoke advisory services for high net worth, family offices, and endowments & foundations, that are customized for the client's individual circumstances. The company helps clients construct and manage alternative asset portfolios, with an emphasis on sustainable alpha strategies, dislocated asset classes, co-investments and partnership approaches. Ivy Academy LLC also provides support with both strategic and tactical asset allocation. Clients benefit from the founder's deep and diverse exposure to hedge funds and other alternative asset classes across many different strategies, geographies, and firm types. Where appropriate, Ivy Academy LLC partners with other external advisors on topics like tax efficiency, estate planning, and charitable giving.

On the admissions counseling side, the company works with accomplished and ambitious students who are applying to top-tier undergraduate and graduate programs. We provide high-touch, multidisciplinary consulting services to guide our clients through all aspects of the admissions process. Ivy Academy LLC has established a global presence, with an emphasis on Chinese students seeking admission to US universities. Importantly, Ivy Academy LLC emphasizes excellence and integrity at all times, while pushing our students to improve themselves, explore their passions, and target optimal schools.

Kevin Lenaghan has more than 20 years of experience in financial services and investment management. He attended the Wharton School of the University of Pennsylvania, where he completed his undergraduate studies as well as his MBA. Kevin is a CFA charterholder and serves as an advisor and pro bono teaching fellow for Musical Mentors Collaborative (http://musical-mentors.org).

"I am proud to leverage my prior investment experience, extensive professional network, and current insights to provide innovative investment solutions for our partners. Global markets are endlessly fascinating and evolving, and I will continue diligently working to identify differentiated alpha opportunities in order to deliver value for clients." says Kevin Lenaghan.

For more information, please visit http://ivyacademyllc.com/.

About Kevin Lenaghan

Kevin Lenaghan has more than 20 years of experience in financial services and investment management, including over 12 years of experience in direct hedge fund investing. He obtained both his undergraduate degree and MBA from the Wharton School of the University of Pennsylvania and is a CFA charterholder. Throughout his career, Kevin has worked with many of the largest and most sophisticated institutional investors on their hedge fund and broader alternatives portfolios, as well as asset allocation. He has regularly spoken at prestigious hedge fund and investment conferences and has been widely cited in leading industry publications. Currently, Mr. Lenaghan is the CEO of Ivy Academy LLC. He lives in Los Angeles, California, with his wife Linda and two children, Benjamin and Emma.

For more information, visit https://kevin-lenaghan.com/.

Contact Information:

Kevin Lenaghan
Email: kevin@ivyacademyllc.com

SOURCE: Kevin Lenaghan

ReleaseID: 618372

What to expect when your newborn needs special care

MISSION, KS / ACCESSWIRE / November 25, 2020 / (Family Features) If you have a baby who is born too early or has serious health problems, he or she may be admitted to the neonatal intensive care unit (NICU), a hospital unit that provides around-the-clock specialized care to newborns.

The NICU can be an overwhelming place with lots of machines, hospital staff and medical terms. If you or someone close to you is pregnant, understanding what to expect if a NICU stay is required can help you focus less on the surroundings and uncertainty and more on taking care of the new baby and yourself.

Learn the ins and outs of the NICU with information from March of Dimes, the nation's leading nonprofit that advocates for the health of all moms and babies, which partners with hospitals across the country through its NICU Family Support® program to provide in-person and online support for families with babies in the NICU.

Common NICU Conditions

Babies born too early and other sick newborns may face a variety of medical issues. Among common causes for a NICU stay may include preterm birth, complications during labor and delivery, birth defects, genetic conditions or other illnesses.

Tests to Expect in the NICU

Your baby may have tests and monitoring done in the NICU to determine health conditions and treatments for him or her to grow and be healthy. Some tests, like blood tests, are common. Others are just for babies with certain health conditions. Depending on his or her condition, your baby might need scans or imaging to find out what's happening, like a CT scan, echocardiogram, MRI, ultrasound or X-ray. You can also expect various screenings for vision and hearing, and monitoring for things like weight changes and urine tests, which can tell health care providers about your baby's overall condition.

Coping with Stress in the NICU

When your baby is in the NICU, it may be hard to think about taking care of yourself. However, taking care of yourself can help you stay well and have more energy to spend time with your baby.

Stick to a daily routine. Every day, take a shower, eat regular meals, drink plenty of water and get a good night's sleep. As part of your routine, decide when you want to be with your baby in the NICU. Schedule breaks from the NICU. It's OK to make time for yourself and the rest of your family.
Follow COVID-19 protocols while connecting with other NICU families at NICU classes, in the family lounge or in the NICU hallways. They may understand what you're experiencing and be able to offer guidance. You can find a supportive online environment that provides advice and resources, and allows you to connect with communities of other NICU families that have had similar experiences, at marchofdimes.org/online-communities.aspx.
You may experience many emotions when your baby's in the NICU. Talking to a counselor may help you sort through your feelings. This may be someone from the NICU staff, a social worker or your religious or spiritual leader. Sometimes it's helpful to talk to someone trained to help you work through stress and navigate challenges like going back to work, the baby blues or postpartum depression.

Paying for Your Baby's NICU Stay

Health insurance helps pay for medical care. You may get health insurance from your employer, from the government or buy it on your own. If your insurance doesn't cover all the health care costs for your baby, ask the NICU social worker or case manager about your options. A social worker can assist you with finding resources and services to help care for your baby. You can also meet with the hospital's finance department about setting up a payment plan. A case manager may also oversee a baby's discharge from the hospital and help set up home care services and supplies, if needed.

Learn more about the NICU and find articles and resources for your family at marchofdimes.org/NICU.

Answers at Your Fingertips

Having a newborn in the NICU can be overwhelming. You're likely to have lots of questions and need access to tools that help you through the NICU stay. You can learn about NICU staff, policies, equipment and terminology on your own schedule with the March of Dimes My NICU Baby App, which provide answers, tools and support so you can focus on your baby during what is often a difficult time.

The app (available for iOS and Android devices) was developed to help parents cope with a baby's early birth, complications like birth defects and other issues that may lead to a NICU stay. It includes features like tracking breastfeeding sessions, breast pumping and kangaroo care time, taking photos and connecting with other families with similar experiences.

Life After the NICU

It can be hard to get used to being at home with your baby after a stay in the NICU. These tips can help you adjust to life at home with your baby:

When you have questions about your baby or your baby's care, call your child's pediatrician.
Take your baby to all his or her well-child visits. These are medical checkups where your baby's health care provider checks his or her health and development to make sure things are going well.
Ask family members, friends and neighbors for help at home. Tell them exactly what you need them to do. For example, tell them if you need help with the laundry, running errands or taking care of your other children.
Take extra steps to keep your baby healthy while he or she is building an immune system, especially during cold and flu season. Limit the number of visitors and only welcome those who are healthy. Ask visitors to wash their hands before touching the baby. Do not allow smoking near your child.

Photos courtesy of Getty Images

Michael French
mfrench@familyfeatures.com
1-888-824-3337
editors.familyfeatures.com

About Family Features Editorial Syndicate

A leading source for high-quality food, lifestyle and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. Find additional articles and information at Culinary.net and eLivingToday.com.

SOURCE: Family Features

ReleaseID: 618382

NEWARK, NJ / ACCESSWIRE / November 25, 2020 / Safety First Healthcare Corp, a Delaware company registered with the Securities & Exchange Commission as a US-form 10 public company with factories in Vietnam specializing in the personal protective equipment business, is seeing another significant surge in demand for PPE products. This new wave is due to the large number of rising cases of Covid-19 and stock piling of PPE equipment globally. The products most in demand are N95 masks and nitrile gloves. However, with the current global surge in Covid-19 cases, Safety First Healthcare is seeing substantial rise in demand for 4-ply surgical masks.

Shaun Morgan, CEO of Safety First Healthcare said, "We are seeing increased purchasing from rising Covid-19 cases and medical community stock piling for the coming winter months. There is also the anticipated mask mandates many governments around the world are implementing or expected to implement."

Safety First Healthcare has two types of 4-ply surgical masks; Protection Masks and Advanced Protection Masks. The difference between the two types is that Protection Masks have a higher than 90% effective filtration layer and the Advanced Protection Masks have a higher than 95% effective filtration layer. Safety First Healthcare Nut95 masks are 5-layer masks which have two higher than 95% effective filtration layers. The filtration layer of all masks is made of a non-woven melt-blown, anti-bacterial fabric.

"The filtration layer of a mask is the most expensive part of mask production. This one layer is 10 times the cost of the other layers of the mask. Therefore, the overall cost of the mask is dependent on the level of protection the filtration layer provides," noted Fredy Bush, Advisory Chairwoman. "With the general public now wearing masks, we are seeing orders for surgical 4-ply masks and N95 masks, which offer high levels of protection, being ordered outside the medical profession. Various types of commercial enterprises such as restaurants and courier companies are now ordering this level of masks for their employees."

Safety First Healthcare is able to produce 250 million 4-ply surgical masks per week and currently has 100 million Advanced Protection Masks in inventory in response to the large number of orders. Additionally, Safety First Healthcare has 5 million Nut95 (N95) masks in inventory.

"Many countries don't have mask manufacturing locally therefore we feel it is incumbent upon companies like Safety First Healthcare to produce large quantities of masks to help governments and people globally," noted Shaun Morgan.

Safety First masks have FDA certification for medical masks and respirator mask, Health Canada, Certificate of Conformity (CE), International Organization for Standardization (ISO), Vinacontrol and other certifications. Many of the certifying bodies conduct a number of tests on each type of mask to qualify for certification. Organizations like ISO check for international standards and best practices of processes and procedures in manufacturing.

Safety First Healthcare provides SGS inspections if requested by the client. An SGS inspection checks for quality and quantity prior to the client taking possession of the goods.

Safety First Healthcare – Premier Producer of Personal Protection Equipment (PPE): http://SafetyFirstHealthcareNews.com

Safety First Healthcare CEO Shaun G. Morgan On the Extensive Offering of FDA-Certified Medical Products: https://www.biospace.com/article/releases/safety-first-healthcare-ceo-shaun-g-morgan-on-the-extensive-offering-of-fda-certified-medical-products/

Safety First Healthcare CEO Shaun G. Morgan On Mobilizing Resources to Help Address PPE Shortage: https://www.yahoo.com/news/safety-first-healthcare-ceo-shaun-163500578.html

Contact Information:
Safety First Healthcare
Fredy Bush
26th Floor, One Gateway Center
Newark, NJ 07102
1-800-657-5645
info@safetyfirst.healthcare
https://safetyfirst.healthcare

SOURCE: Safety First Healthcare

ReleaseID: 618398

Correction of the press release published November 24, 2020: It has come to our attention that a mistake was printed in the percentage of control patients in the EAP who survived to day 28. The correct percentage is 27%, not 17% of the control patients, all treated with best available intensive care unit (ICU) Standard of Care, survived to day 28. This has been corrected in the text below.

GENEVA, SWITZERLAND and RADNOR, PA / ACCESSWIRE / November 25, 2020 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company") and NeuroRx, Inc., announced that more than 175 patients with Critical COVID-19 and Respiratory Failure who also have a severe comorbidity have now been entered into an Expanded Access Protocol (EAP) with RLF-100(TM) in the United States.

All patients had severe comorbidities (such as organ transplant, recent heart attack, and cancer) that rendered them ineligible for the ongoing randomized, controlled phase 2b/3 trial being conducted to ascertain safety and efficacy of RLF-100(TM), and all patients were deteriorating despite treatment with approved therapies for COVID-19 (see www.clinicaltrials.gov NCT 04311697). Of the 90 patients who have so far reached 28 days of follow-up, 72% survived to day 28.

As previously reported by Youssef and coworkers (http://dx.doi.org/10.2139/ssrn.3665228), at Houston Methodist Hospital, 21 patients treated with RLF-100(TM) under the EAP were compared to 24 control patients treated in the same setting. Only 27% of the control patients, all treated with best available intensive care unit (ICU) Standard of Care, survived to day 28. The survival rate with RLF-100(TM) reported today is comparable to that seen among the open-label patients treated with RLF-100(TM) by Youssef et al. Despite advancements in treating COVID-19, survival for the patients at highest risk due to severe comorbidities has remained dismal in the absence of an effective therapy.

Notably, in the EAP, no drug-related Serious Adverse Events have been reported to date among these patients nor the 160 patients randomized to RLF-100(TM) vs. placebo in the U.S. phase 2b/3 clinical trial currently underway. Thus, from a risk/benefit perspective, while the benefit of RLF-100(TM) has not yet been proven in a randomized prospective trial, no serious risk has been identified so far.

Currently, 25 U.S. hospitals have enrolled patients in the EAP, nearly all of which are community hospitals, suggesting that RLF-100(TM) can demonstrate effectiveness in the hands of front-line physicians who deliver the majority of care to patients with Critical COVID-19. Physicians enrolling patients in the EAP have routinely reported that initial patients at their sites have frequently been in the ICU for several weeks without recovery prior to treatment with RLF-100(TM). As patients are treated earlier in the course of their ICU stay, there is an emerging clinical impression that RLF-100(TM) has an even greater impact on recovery.

"We are reassured that emerging real-world data on the use of RLF-100(TM) in improving survival in patients with Critical COVID-19 are comparable to results seen in the hands of major academic teaching centers. We hope that these findings are viewed as encouraging at a time when many Americans, including the doctors, nurses, and other front-line caregivers who are the heart of our initiative, are celebrating the Thanksgiving holiday at a distance from their loved ones. We look forward to completing enrollment and reporting the results of our pivotal U.S. clinical trial," said Prof. Jonathan C. Javitt, MD, MPH, CEO and founder of NeuroRx, Inc.

###

ABOUT VIP IN LUNG INJURY
Vasoactive Intestinal Polypeptide (VIP) was first discovered by the late Dr. Sami Said in 1970. Although first identified in the intestinal tract, VIP is now known to be produced throughout the body and to be primarily concentrated in the lungs. VIP has been shown in more than 100 peer-reviewed studies to have potent anti-inflammatory/anti-cytokine activity in animal models of respiratory distress, acute lung injury, and inflammation. Most importantly, 70% of the VIP in the body is bound to a rare cell in the lung, the alveolar type 2 cell, that is critical to transmission of oxygen to the body. VIP has a 20-year history of safe use in humans in multiple human trials for sarcoidosis, pulmonary fibrosis, asthma/allergy, and pulmonary hypertension.

COVID-19-related death is primarily caused by respiratory failure. Before this acute phase, however, there is evidence of early viral infection of the alveolar type 2 cells. These cells are known to have angiotensin converting enzyme 2 (ACE2) receptors at high levels, which serve as the route of entry for the SARS-CoV-2 into the cells. Coronaviruses are shown to replicate in alveolar type 2 cells but not in the more numerous type 1 cells. These same type 2 alveolar cells have high concentrations of VIP receptors on their cell surfaces giving rise to the hypothesis that VIP could specifically protect these cells from injury.

Injury to the type 2 alveolar cells is an increasingly plausible mechanism of COVID-19 disease progression (Mason 2020). These specialized cells replenish the more common type 1 cells that line the lungs. More importantly, type 2 cells manufacture surfactant that coats the lung and are essential for oxygen exchange. Other than RLF-100(TM), no currently proposed treatments for COVID-19 specifically target these vulnerable type 2 cells.

ABOUT RLF-100(TM)
RLF-100(TM) (Aviptadil) is a formulation of Vasoactive Intestinal Polypeptide (VIP) that was developed based on Dr. Sami Said's original work at Stony Brook University, for which Stony Brook was awarded an FDA Orphan Drug Designation in 2001. VIP is known to be highly concentrated in the lungs, where it inhibits coronavirus replication, blocks the formation of inflammatory cytokines, prevents cell death, and upregulates the production of surfactant. FDA has now granted IND authorization for intravenous and inhaled delivery of RLF-100(TM) for the treatment of COVID-19 and awarded Fast Track designation. RLF-100(TM) is being investigated in two placebo-controlled US Phase 2b/3 clinical trials in respiratory deficiency due to COVID-19. Since July 2020, more than 150 patients with Critical COVID-19 and Respiratory Failure have been treated with RLF-100(TM) under FDA-approved protocols. Information on the RLF-100(TM) Expanded Access program is at https://www.neurorxpharma.com/our-services/rlf-100.

ABOUT RELIEF THERAPEUTICS HOLDING AG
Relief focuses primarily on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rationale. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications. Relief holds orphan drug designations from the U.S. FDA and the European Union for the use of VIP to treat ARDS, pulmonary hypertension, and sarcoidosis. Relief also holds a patent issued in the U.S. and multiple other countries covering potential formulations of RLF-100(TM).

RELIEF THERAPEUTICS Holding AG is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on the OTCQB under the symbol RLFTF.

ABOUT NEURORX INC.
NeuroRx draws upon more than 100 years of collective drug development experience and is led by former senior executives of Johnson & Johnson, Eli Lilly, Pfizer, and AstraZeneca, PPD. In addition to its work on RLF-100(TM), NeuroRx has been awarded Breakthrough Therapy Designation and a Special Protocol Agreement to develop NRX-101 in suicidal bipolar depression and is currently in Phase 3 trials. Its executive team is led by Prof. Jonathan C. Javitt, MD, MPH, who has served as a health advisor to four Presidential administrations and worked on paradigm-changing drug development projects for Merck, Allergan, Pharmacia, Pfizer, Novartis, and Mannkind, together with Robert Besthof, MIM, who served as the Global Vice President (Commercial) for Pfizer's Neuroscience and Pain Division. Its Board of Directors and Advisors includes Hon. Sherry Glied, former Assistant Secretary, U.S. Dept. of Health and Human Services; Mr. Chaim Hurvitz, former President of the Teva International Group, Lt. Gen. HR McMaster, the 23rd National Security Advisor, Wayne Pines, former Associate Commissioner of the U.S. Food and Drug Administration, Judge Abraham Sofaer, and Daniel Troy, former Chief Counsel, U.S. Food and Drug Administration.

Disclaimer: This communication expressly or implicitly contains certain forward-looking statements concerning RELIEF THERAPEUTICS Holding AG, NeuroRx, Inc. and their businesses. The results reported herein may or may not be indicative of the results of future and larger clinical trials for RLF-100(TM) for the treatment of COVID-19. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of RELIEF THERAPEUTICS Holding AG and/or NeuroRx, Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. RELIEF THERAPEUTICS Holding AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

CORPORATE CONTACT
RELIEF THERAPEUTICS Holding AG
Raghuram (Ram) Selvaraju, Ph.D., MBA
Chairman of the Board
Mail: contact@relieftherapeutics.com
www.relieftherapeutics.com

NeuroRx, Inc.
Jonathan C. Javitt, M.D., MPH
Chairman and Chief Executive Officer
Mail: ceo@neurorxpharma.com

MEDIA CONTACT:
Relief (Europe)
MC Services AG
Anne Hennecke / Brittney Sojeva
Tel.: +49 (0) 211-529-252-14
Mail: relief@mc-services.eu

NeuroRx (United States)
David Schull
Russo Partners, LLC
Tel.: +1 (0) 858-717-2310
Mail: david.schull@russopartnersllc.com

INVESTOR RELATIONS
Relief (Europe)
MC Services AG
Anne Hennecke / Brittney Sojeva
Tel.: +49 (0) 211-529-252-14
Mail: relief@mc-services.eu

NeuroRx (United States)
Brian Korb
Solebury Trout
Tel.: +1 (0) 917-653-5122
Mail: bkorb@troutgroup.com

SOURCE: Relief Therapeutics Holdings AG

ReleaseID: 618414

Technology is Helping Patients Improve Pain and Overcome Neuropathic Disorders, Explains Richard Sorgnard

LAS VEGAS, NV / ACCESSWIRE / November 25, 2020 / Technology in the medical industry has been used for decades. However, it is mostly used to aid doctors. Now, electric signal generation technology is being used to aid patients. Richard Sorgnard has developed a number of tools to help with neuropathic disorders.

Richard Sorgnard is both the executive director for Morhea Technologies and the Director of Technology for the International Institute for Chronic Disease. He works regularly with electric signal generation technology and applies the techniques throughout the medical and governmental industries. Under the Morhea license, Richard Sorgnard has developed proprietary technology being used by a variety of companies throughout the medical industry.

As someone who has a Ph.D. in molecular cell biology, Richard Sorgnard is particularly interested in how electric signal generation can impact cells. This is what led to the development of RST-Sanexas. As the recognized leader of quantum-based electric cell signaling technology, it is being used for pain and circulatory management. It was originally developed as a way to treat acute and chronic pain as well as severe neuropathic pain.

Richard Sorgnard explains how electronic signal intonation (ESI) is a patented, communications-level technology that has delivered unprecedented patient outcomes. A variety of studies have been published in medical journals to describe its efficacy with patients.

The RST-Sanexas medical device that Richard Sorgnard developed is the only electric cell signaling device that has been used in clinical research. More specifically, it has proven that it has the capacity to regenerate nerves and reverse painful peripheral neuropathy. With over 30 published medical reports to discuss its impact on neuropathic conditions, the device has proven to be safe and effective. Richard Sorgnard also identifies that it can be reimbursed by Medicare.

While so many devices on the market are designed to mask symptoms and simply address pain, Richard Sorgnard discusses how this technology is capable of changing the way that patients are treated. It is possible to reverse the neuropathy and regenerate nerves so that there are no more medical issues. This provides a wide array of benefits to patients as they no longer have to focus solely on treating the pain.

The physics-based technology that Richard Sorgnard has created illustrates how quantum mechanics can support electromagnetic therapies for pain management. A frequency hopping FM signal generator is combined with communications-level technology to produce signal energy waves. These waves are continually varying with sequential and random patterns that are applied transcutaneously to the skin via electrodes.

Through the work that Richard Sorgnard has done, doctors are learning that they can now heal the cause of neuropathy as well as other painful conditions instead of masking the symptoms. It is a revolutionary technology that is becoming more readily available to hospitals and medical facilities around the globe. He continues to work with various companies to explore how the technology can help patients in other ways.

Caroline Hunter
Web Presence, LLC
+1 786-551-9491

SOURCE: Richard Sorgnard

ReleaseID: 618438

EDMONTON, AB / ACCESSWIRE / November 25, 2020 / Rocky Mountain Liquor Inc. (TSXV:RUM) (the "Company" or "Rocky Mountain"), listed on the TSX Venture Exchange (the "Exchange"), today reported its unaudited financial results for the three month and nine month periods ending September 30, 2020.

The Company has continued to succeed at its objective to grow market share and reduce costs, having increased income from operations by $327,185 for the three month period in 2020 and $1.2M for the nine month period when compared to the same periods in 2019. Sales have increased by $1.4M for the three month period of 2020 and $4.1M for the nine month period. The 36% growth in income from operations in the three month period, and 58% in the nine month period is a result of an increase in sales of 12% in both the three and nine month periods in 2020 while managing operating and administrative expenses.

As at November 25, 2020, all locations are open and operational. The novel coronavirus pandemic continues to positively impact sales at the Company. The Company's financial results show increased sales, driven by increased demand for liquor product following the onset of the crisis and continuing through the year as a result of consumers choosing liquor retailers in lieu of licensed establishments during the COVID-19 pandemic. We continue to incur additional costs for safety and sanitization measures to ensure our employees and customers are working and shopping in a safe environment. The Company has increased sanitation throughout the stores, installed plexiglass shields at counters, installed touchless sanitation units for customer and staff use at store entrances, mandated masks for staff at all locations, provide masks to customers, maintains social distancing measures within the locations, and restricts the number of individuals in the store at a time.

After removing a non-recurring gain of $3.5M from net income in 2019 resulting from the redemption of the Company's convertible debenture, there is an increase in net income for the three month period of $567,499 and nine month period of $2.0M in 2020 over 2019. This is a result management's continued focus on competitive pricing strategies, an increase in sales and reduction to finance costs. The Company remains focused on delivering efficiency and process improvements while managing operating costs.

KEY OPERATING AND FINANCIAL METRICS

Financial highlights, year over year 3 month comparison:

Sales increased by $1.4M or 12% to $13.2M (2019 was $11.8M) with 26 stores contributing to sales at the end of the period in 2020 versus 29 at the end of the period in 2019
EBITDAR* increased by 36% to $1.2M (2019 was $909,433)
Gross margin percentage increased to 22.8% (2019 was 22.0%)
Income from operations increased by $327,185 or 36% to $1,236,165 (2019 was $908,980)
Net income is $690,782 (2019 was $123,283 after adjusting for a non-recurring gain of $3.5M as a result of convertible debenture redemption)

Financial highlights, year over year 9 month comparison:

Sales increased by $4.1M or 12%, to $37.0M (2019 was $32.9M) with 26 stores contributing to sales at the end of the period in 2020 versus 29 at the end of the period in 2019
EBITDAR* increased by $1.2M to $3.3M (2019 was $2.1M)
Gross margin percentage increased to 22.8% (2019 was 21.9%)
Income from operations increased by $1.2M or 58% to $3.3M (2019 was $2.1M)
Net income is $1.4M (2019 net loss was $599,438 after adjusting for a non-recurring gain of $3.5M as a result of convertible debenture redemption)

Margins have increased from 22.0% to 22.8% for the three month period and 21.9% to 22.8% for the nine month period, as the Company has modeled its marketing, pricing and promotional strategies to maximize gross margins. The Company strategizes the timing of Limited Time Offer purchases with in store promotions, to realize margin growth.

Income from operations as a percent of sales increased to 9.4% from 7.7% for the three month period 2020, and to 9.1% from 6.4% for the nine month period. The increase in income from operations is a result of the increase in sales as well as a 4% increase to gross margins in both periods while managing operating and administrative expenses.

To date, the COVID-19 pandemic has not had a negative impact on the Company's results of operations, however, the Company is not immune to factors beyond its control, including without limitation; forced store closures, labour shortages, potential supply disruptions or other unforeseen circumstances.

At September 30, 2020 the Company operated 26 stores.

*EBITDAR is Earnings before Interest, Taxes, Depreciation, Amortization and Rent.

Going Concern

The going concern basis assumes the Company will continue in operation for the foreseeable future and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Based on the continued improvement of the Company's performance and statement of financial position we are no longer including disclosure of the uncertainty of the Company as a going concern.

Detailed information in the form of the Company's interim consolidated financial statements and Management Discussion and Analysis are available under the Company's profile on SEDAR at www.sedar.com and also on the Company's website at www.ruminvestor.com. After accessing the website, please choose the "Investor Relations" tab to view Quarterly Reports.

About Rocky Mountain

Rocky Mountain owns 100% of Andersons Liquor Inc. ("Andersons"), headquartered in Edmonton, Alberta, which now own and operate 26 private liquor stores in that province, up from 18 stores since the Common Shares began trading in December 2008. It is listed on the TSX Venture Exchange (TSX-V:RUM).

Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Forward-looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as investment decisions. In particular results achieved in 2020 and previous periods might not be a certain indication of future performance, which is subject to other risks, including but not limited to changes in operational policies, changes in management, changes in strategic focus, market conditions and customer preferences, the impact from COVID-19 pandemic on our operations and third party suppliers. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks, the risks that these events may not materialize as well as those additional factors discussed in the section entitled "Risk Factors" in RUM's Management Discussion and Analysis, which can be obtained at www.sedar.com. If they do materialize, there remains a risk of non-execution for any reason. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release.

The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the TSX-V. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Allison Radford
Chief Executive Officer
(780) 483-8183

Sarah Stelmack
Chief Financial Officer
(780) 483-8177

SOURCE : Rocky Mountain Liquor Inc.

ReleaseID: 618459

ST PETERSBURG, FL / ACCESSWIRE / November 25, 2020 / As most businesses know, Wi-Fi is no longer an amenity- it is an expectation. No matter where people go, they want to look at information on their phones, and they do not want to burn through their personal data plans. GoZone WiFi is offering restaurants, bars, and cafes an opportunity to provide Wi-Fi and get valuable data in return without compromising the business' security.

GoZone WiFi Invites Customers to Stay

A customer will wait ten minutes or fewer before trying to log into a bar, restaurant, or café Wi-Fi system. Customers will invariably spend more time at a place that offers free WiFi, and they will also spend more money on those premises. The unfortunate downside is that running these systems costs money. However, using GoZone WiFi's software shifts the cost-benefit ratio back in favor of the businesses that implement it.

In short, the cost of providing guest Wi-Fi pales in comparison to the revenue and engagement a company generates from the actionable data gathered by implementing the newest tool in the marketing arsenal- restaurant Wi-Fi marketing.

Setting a Gateway on Your Wi-Fi Connection

GoZone WiFi's Marketing4Wifi tool provides customers unfettered and speedy access to a business' Wi-Fi. All they must do is sign in through what is known as a captive portal. Customers gain access to the venue's free Wi-Fi once they choose to enter the portal by logging in with:

Email
Social media
SMS
Custom survey

Not only does this login procedure protect your network from outsider incursions by limiting access to passwords, but it is the key to providing the company with information about the customers' behavior on the network.

Gaining and Leveraging Actionable Data with GoZone WiFi

When customers use a bar's Wi-Fi through this system, that business will gain access to valuable data such as:

Identifying new and returning guests
The number of times a customer has accessed your network
Devices used to access the network
Most frequent Wi-Fi Guests
Demographic data
And more

This information provides businesses with many incredible benefits and insights into their customer base. Combined with a contact management add on provided by GoZone WiFi, the bar can instantly develop profiles on customers to start effectively leveraging the data to its benefit.

The insights gleaned from the data can also be utilized in some of the following ways:

Implementing a rewards system for those who use the Wi-Fi

Frequent logins could lead to coupons, extending the customer's stay, and increasing the amount of money they spend.

Increasing engagement on social media websites

Social media engagement leads to new customers finding the business

Targeting marketing campaigns

Reaching out to specific demographics, such as age or sports fans, can result in increased foot traffic during prime times

Using the custom survey tool to collect more direct customer reviews and input
Developing a massive list of emails for marketing campaigns

Implementing GoZone WiFi's system in any bar, restaurant, or café can help a business increase customer loyalty, offer their customers a great Wi-Fi experience, and position itself to more effectively market to their chosen demographics. Adding this system is a simple, proven way to give businesses a higher ROI on Wi-Fi, ensuring a mutually beneficial interaction between them and their clients.

CONTACT:
Asa Hedstrom
asa@gozonewifi.com
(727) 314-6910

SOURCE: GoZone WiFi

ReleaseID: 618394

With the COVID-19 Pandemic Impacting Every Industry, Shane Richard Roybal Is Here to Discuss the Impact from a Technological Perspective

WHEAT RIDGE, CO / ACCESSWIRE / November 25, 2020 / The COVID-19 pandemic has impacted everyone. There is no industry that has been left untouched and both businesses and residences are seeing the technological consequences of this virus. Shane Richard Roybal is a tech expert and he is here to discuss some of the major changes that have taken place in the world of tech during the pandemic.

Shane Richard Roybal Reviews the Impacts of Working from Home During the Pandemic

One of the biggest shifts that Shane Richard Roybal has noticed during the pandemic has been an increase in the number of people who are working remotely. With businesses aiming to avoid transmission of the virus in the workplace, more and more people are now working from home than ever before. At the same time, Shane Richard Roybal knows that this has had impacts on the tech world as well. Remote employees are placing greater demands on their current household bandwidth, meaning that devices, as well as their internet connections, might have a hard time keeping up. When this is combined with kids partaking in remote learning, it is easy to see how these demands are testing the IT infrastructure in our cities.

Shane Richard Roybal Highlights the Growth of Telehealth in the World of Healthcare

Another major shift that Shane Richard Roybal has noticed has been the growth of something called telehealth. Without a doubt, the healthcare industry has been strained during the pandemic. At the same time, many people do not want to leave their homes to go to the doctor's office. As a result, Shane Richard Roybal has noticed an increase in the number of people who are communicating with their doctor from home through video-conferencing or online chat sessions, in place of in-person visits. Tech advances have made this type of virtual visit possible for so many people, reducing barriers to care. This type of care presents a paradigm shift in the health industry, which has become a familiarity to many Americans due to the pandemic.

Shane Richard Roybal Looks at the Importance of a Secure Internet Connection in This New Working Environment

Finally, Shane Richard Roybal also wants to highlight the importance of a secure internet connection in this new era. There are countless people who are looking for ways to access the information they need to do their jobs from home. At the same time, Shane Richard Roybal wants to encourage employees and companies to take a look at ways they can keep their data safe while employees work from home. Using VPNs and other advanced security measures allow confidential and critical information to be transferred securely between home and office. As an IT specialist, Shane Richard Roybal is working with enterprises of all sizes to assist companies with managing their developing IT infrastructure concerns amidst the pandemic, as it is critical to prioritize cybersecurity in this new working environment.

https://www.54invest.com/

CONTACT:
Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Shane Roybal

ReleaseID: 618390